Differential influence of inositol hexaphosphate on the expression of genes encoding TGF-β isoforms and their receptors in intestinal epithelial cells stimulated with proinflammatory agents

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Kapral, Małgorzata ^a   Wawszczyk, Joanna ^a   Sośnicki, Stanisław ^a   Wȩglarz, Ludmiła ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; INTERLEUKIN 1BETA; MESSENGER RNA; PHYTIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; ISOPROTEIN; LIPOPOLYSACCHARIDE;

ARTICLE; CELL STRAIN CACO 2; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHI; UPREGULATION; CACO 2 CELL LINE; GENETICS; INTESTINE MUCOSA; METABOLISM;

CACO-2 CELLS; HUMANS; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; PHYTIC ACID; PROTEIN ISOFORMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84896331070     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/436894     Document Type: Article

References (53)

1. Baumgart D. C., Carding S. R., Inflammatory bowel disease: cause and immunobiology. The Lancet 2007 369 9573 1627 1640 2-s2.0-34248136828 10.1016/S0140-6736(07)60750-8 (Pubitemid 46722636)
2. Böcker U., Yezerskyy O., Feick P., Manigold T., Panja A., Kalina U., Herweck F., Rossol S., Singer M. V., Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. International Journal of Colorectal Disease 2003 18 1 25 32 2-s2.0-0038804192 10.1007/s00384-002-0415-6 (Pubitemid 36764134)
3. Al-Sadi R. M., Ma T. Y., IL-1 β causes an increase in intestinal epithelial tight junction permeability. Journal of Immunology 2007 178 7 4641 4649 2-s2.0-33947631511 (Pubitemid 46492417)
4. Ligumsky M., Simon P. L., Karmeli F., Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990 31 6 686 689 2-s2.0-0025442212
5. Hong S., Lee H.-J., Kim S. J., Hahm K.-B., Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF- β signaling. World Journal of Gastroenterology 2010 16 17 2080 2093 2-s2.0-77952524907 10.3748/wjg.v16.i17.2080
6. Elliott R. L., Blobe G. C., Role of transforming growth factor beta in human cancer. Journal of Clinical Oncology 2005 23 9 2078 2093 2-s2.0-15744372725 10.1200/JCO.2005.02.047 (Pubitemid 46211385)
7. Bierie B., Moses H. L., Transforming growth factor beta (TGF- β) and inflammation in cancer. Cytokine and Growth Factor Reviews 2010 21 1 49 59 2-s2.0-77549083441 10.1016/j.cytogfr.2009.11.008
8. Paduch R., Niedziela P., TGF-beta1 influence on TNF-alpha production and sTNF-Rs shedding in a coculture of colon carcinoma cell spheroids with normal cells. In Vitro Cellular and Developmental Biology 2009 45 7 371 377 2-s2.0-70449708055 10.1007/s11626-009-9190-9
9. Yang L., Pang Y., Moses H. L., TGF- β and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends in Immunology 2010 31 6 220 227 2-s2.0-77953023274 10.1016/j.it.2010.04.002
10. Kubiczkova L., Sedlarikova L., Hajek R., TGF- β-an excellent servant but a bad master. Journal of Translational Medicine 2012 10 183 207 10.1186/1479-5876-10-183
11. Heldin C.-H., Miyazono K., Ten Dijke P., TGF- β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997 390 6659 465 471 2-s2.0-0031438047 10.1038/37284 (Pubitemid 28013118)
12. Moustakas A., Heldin C.-H., The regulation of TGF β signal transduction. Development 2009 136 22 3699 3714 2-s2.0-70450187617 10.1242/dev.030338
13. Bitzer M., von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A. A., Rojkind M., Böttinger E. P., A mechanism of suppression of TGF- β /SMAD signaling by NF- B/RelA. Genes and Development 2000 14 2 187 197 2-s2.0-0034650266 (Pubitemid 30070984)
14. Rizzo A., Waldner M. J., Stolfi C., Sarra M., Fina D., Becker C., Neurath M. F., Macdonald T. T., Pallone F., Monteleone G., Fantini M. C., Smad7 expression in T cells prevents colitis-associated cancer. Cancer Research 2011 71 24 7423 7432 2-s2.0-84255192090 10.1158/0008-5472.CAN-11-1895
15. Massague J., TGF β signalling in context. Nature Reviews Molecular Cell Biology 2012 13 10 616 630
16. Saif M. W., Chu E., Biology of colorectal cancer. Cancer Journal 2010 16 3 196 201 2-s2.0-77953626157 10.1097/PPO.0b013e3181e076af
17. Hahm K.-B., Im Y.-H., Parks T. W., Park S.-H., Green J., Kim S.-J., Markowitz S., Jung H.-Y., Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001 49 2 190 198 2-s2.0-0034924028 10.1136/gut.49.2.190 (Pubitemid 32675110)
18. Santibañez J. F. S., Quintanilla M., Bernabeu C., TGF- β /TGF- β receptor system and its role in physiological and pathological conditions. Clinical Science 2011 121 6 233 251 2-s2.0-79961139550 10.1042/CS20110086
19. Monteleone G., Kumberova A., Croft N. M., McKenzie C., Steer H. W., MacDonald T. T., Blocking Smad7 restores TGF- β 1 signaling in chronic inflammatory bowel disease. The Journal of Clinical Investigation 2001 108 4 601 609 2-s2.0-0034894059 10.1172/JCI200112821 (Pubitemid 32777740)
20. Monteleone G., Caruso R., Pallone F., Role of Smad7 in inflammatory bowel diseases. World Journal of Gastroenterology 2012 18 40 5664 5668
21. Hussain S. P., Harris C. C., Inflammation and cancer: an ancient link with novel potentials. International Journal of Cancer 2007 121 11 2373 2380 2-s2.0-35648983903 10.1002/ijc.23173 (Pubitemid 350022405)
22. Lu H., Ouyang W., Huang C., Inflammation, a key event in cancer development. Molecular Cancer Research 2006 4 4 221 233 2-s2.0-33646160623 10.1158/1541-7786.MCR-05-0261
23. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010 127 12 2893 2917 2-s2.0-78049485263 10.1002/ijc.25516
24. Rousseau B., Chibaudel B., Bachet J.-B., Larsen A. K., Tournigand C., Louvet C., André T., De Gramont A., Stage II and stage III colon cancer: treatment advances and future directions. Cancer Journal 2010 16 3 202 209 2-s2.0-77953624228 10.1097/PPO.0b013e3181ddc5bf
25. Thompson P. A., Gerner E. W., Current concepts in colorectal cancer prevention. Expert Review of Gastroenterology and Hepatology 2009 3 4 369 382 2-s2.0-70049110388 10.1586/egh.09.28
26. Vucenik I., Shamsuddin A. M., Protection against cancer by dietary IP6 and inositol. Nutrition and Cancer 2006 55 2 109 125 2-s2.0-33750846875 10.1207/s15327914nc5502-1 (Pubitemid 44719624)
27. Gu M., Raina K., Agarwal C., Agarwal R., Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells. Molecular Carcinogenesis 2010 49 1 1 12 2-s2.0-74249091558 10.1002/mc.20560
28. Matejuk A., Shamsuddin A., IP6 in cancer therapy: past, present and future. Current Cancer Therapy Reviews 2010 6 1 1 12 2-s2.0-77949883130 10.2174/157339410790596443
29. Liao J., Seril D. N., Yang A. L., Lu G. G., Yang G.-Y., Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds. Carcinogenesis 2007 28 2 446 454 2-s2.0-33847301060 10.1093/carcin/bgl154 (Pubitemid 46321862)
30. Kapral M., Wawszczyk J., Hollek A., Induction of the expression of genes encoding TGF- β isoforms and their receptors by inositol hexaphosphate in human colon cancer cells. Acta Poloniae Pharmaceutica 2013 70 2 357 363
31. Kapral M., Parfiniewicz B., Strzałka-Mrozik B., Zachacz A., Wglarz L., Evaluation of the expression of transcriptional factor NF- B induced by phytic acid in colon cancer cells. Acta Poloniae Pharmaceutica 2008 65 6 697 702 2-s2.0-61549131213
32. Kim Y. S., Young M. R., Bobe G., Colburn N. H., Milner J. A., Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prevention Research 2009 2 3 200 208 2-s2.0-68349100034 10.1158/1940-6207.CAPR-08-0141
33. Davis C. D., Nutritional interactions: credentialing of molecular targets for cancer prevention. Experimental Biology and Medicine 2007 232 2 176 183 2-s2.0-33846829565 (Pubitemid 46203285)
34. Cherng J.-M., Chiang W., Chiang L.-C., Immunomodulatory activities of edible beans and related constituents from soybean. Food Chemistry 2007 104 2 613 618 2-s2.0-34247530254 10.1016/j.foodchem.2006.12.011 (Pubitemid 46661066)
35. Wglarz L., Wawszczyk J., Orchel A., Jaworska-Kik M., Dzierzewicz Z., Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1 β Digestive Diseases and Sciences 2007 52 1 93 102 2-s2.0-33846378900 10.1007/s10620-006-9320-0 (Pubitemid 46127369)
36. Cholewa K., Parfiniewicz B., Bednarek I., Świtkowska L., Jezienicka E., Kierot J., Wglarz L., The influence of phytic acid on TNF- α and its receptors genes' expression in colon cancer Caco-2 cells. Acta Poloniae Pharmaceutica 2008 65 1 75 79 2-s2.0-42549139289 (Pubitemid 351578431)
37. Wawszczyk J., Kapral M., Hollek A., The effect of phytic acid on the expression of NF- B, IL-6 and IL-8 in IL-1 β -stimulated human colonic epithelial cells. Acta Poloniae Pharmaceutica 2012 69 6 1313 1319
38. Zeuthen L. H., Fink L. N., Frokiaer H., Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor- β Immunology 2008 123 2 197 208 2-s2.0-37849032964 10.1111/j.1365-2567.2007.02687.x
39. Haller D., Bode C., Hammes W. P., Pfeifer A. M. A., Schiffrin E. J., Blum S., Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000 47 1 79 87 2-s2.0-0002647979 10.1136/gut.47.1.79 (Pubitemid 30430415)
40. Yoshioka T., Morimoto Y., Iwagaki H., Itoh H., Saito S., Kobayashi N., Yagi T., Tanaka N., Bacterial lipopolysaccharide induces transforming growth factor β and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells. Journal of International Medical Research 2001 29 5 409 420 2-s2.0-0035153786 (Pubitemid 33061660)
41. van de Walle J., Hendrickx A., Romier B., Larondelle Y., Schneider Y.-J., Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation. Toxicology in Vitro 2010 24 5 1441 1449 2-s2.0-77953618595 10.1016/j.tiv.2010.04.002
42. Rossol M., Heine H., Meusch U., Quandt D., Klein C., Sweet M. J., Hauschildt S., LPS-induced cytokine production in human monocytes and macrophages. Critical Reviews in Immunology 2011 31 5 379 446 2-s2.0-82755187765
43. Bahrami B., Macfarlane S., Macfarlane G. T., Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. Journal of Applied Microbiology 2011 110 1 353 363 2-s2.0-78650166351 10.1111/j.1365-2672. 2010.04889.x
44. Drygiannakis I., Valatas V., Sfakianaki O., Bourikas L., Manousou P., Kambas K., Ritis K., Kolios G., Kouroumalis E., Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis. Journal of Crohn's and Colitis 2013 7 4 286 300 2-s2.0-84860608453 10.1016/j.crohns.2012.04.008
45. McAlindon M. E., Hawkey C. J., Mahida Y. R., Expression of interleukin 1 β and interleukin 1 β converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 1998 42 2 214 219 2-s2.0-0031921472 (Pubitemid 28212176)
46. Apte R. N., Voronov E., Interleukin-1-major pleiotropic cytokine in tumor-host interactions. Seminars in Cancer Biology 2002 12 4 277 290 (Pubitemid 35034572)
47. de Crescenzo G., Grothe S., Zwaagstra J., Tsang M., O'Connor-McCourt M. D., Real-time monitoring of the interactions of transforming growth factor- β (TGF- β) isoforms with latency-associated protein and the ectodomains of the TGF- β type II and III receptors reveals different kinetic models and stoichiometries of binding. The Journal of Biological Chemistry 2001 276 32 29632 29643 2-s2.0-0035839642 10.1074/jbc.M009765200
48. Mckaig B. C., Hughes K., Tighe P. J., Mahida A. Y. R., Differential expression of TGF- β isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. American Journal of Physiology: Cell Physiology 2002 282 1 C172 C182 2-s2.0-0036073299 (Pubitemid 34662564)
49. Lee Y.-J., Han Y., Lu H.-T., Nguyen V., Qin H., Howe P. H., Hocevar B. A., Boss J. M., Ransohoff R. M., Benveniste E. N., TGF- β suppresses IFN- γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. Journal of Immunology 1997 158 5 2065 2075 2-s2.0-0031093495 (Pubitemid 127469987)
50. Di Sabatino A., Jackson C. L., Pickard K. M., Buckley M., Rovedatti L., Leakey N. A. B., Picariello L., Cazzola P., Monteleone G., Tonelli F., Corazza G. R., MacDonald T. T., Pender S. L., Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut 2009 58 6 777 789 2-s2.0-66649106333 10.1136/gut.2008.149096
51. Rahal K., Schmiedlin-Ren P., Adler J., Dhanani M., Sultani V., Rittershaus A. C., Reingold L., Zhu J., McKenna B. J., Christman G. M., Zimmermann E. M., Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease. Inflammatory Bowel Diseases 2012 18 4 613 623 2-s2.0-84858705832 10.1002/ibd.21843
52. Kapral M., Wawszczyk J., Jurzak M., Hollek A., Weglarz L., The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1 β -stimulated colon cancer cells. International Journal of Colorectal Disease 2012 27 11 1419 1428 2-s2.0-84857929646 10.1007/s00384-012-1445-3
53. Kamp D. W., Israbian V. A., Yeldandi A. V., Panos R. J., Graceffa P., Weitzman S. A., Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos. Toxicologic Pathology 1995 23 6 689 695 2-s2.0-0029621132 (Pubitemid 26021843)